sphingosine

sphingosine is a lipid of Sphingolipids (SP) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 26061 references associated with sphingosine in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for sphingosine

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with sphingosine

Download all related citations
Per page 10 20 50 100 | Total 6563
Authors Title Published Journal PubMed Link
Ouairy CM et al. Development of an acid ceramidase activity-based probe. 2015 Chem. Commun. (Camb.) pmid:25748248
Desai P et al. Dyslipidemia regulates thrombospondin-1-induced vascular smooth muscle cell chemotaxis. 2015 Mol. Cell. Biochem. pmid:26350564
Ohkawa R et al. Possible involvement of sphingomyelin in the regulation of the plasma sphingosine 1-phosphate level in human subjects. 2015 Clin. Biochem. pmid:25863111
Radue EW et al. Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis. 2015 Neurology pmid:25632085
Wang L et al. Junctional complex and focal adhesion rearrangement mediates pulmonary endothelial barrier enhancement by FTY720 S-phosphonate. 2015 Microvasc. Res. pmid:25862132
Kolahdooz Z et al. Sphingosin-1-phosphate Receptor 1: a Potential Target to Inhibit Neuroinflammation and Restore the Sphingosin-1-phosphate Metabolism. 2015 Can J Neurol Sci pmid:25860537
Ren K et al. Apolipoprotein M. 2015 Clin. Chim. Acta pmid:25858547
Thomas RH and Wakefield RA Oral disease-modifying therapies for relapsing-remitting multiple sclerosis. 2015 Am J Health Syst Pharm pmid:25511835
Moolenaar WH Introduction to the ECR special issue on lysophospholipids in biology. 2015 Exp. Cell Res. pmid:25746723
Zhao S and Li J Sphingosine-1-phosphate induces the migration of thyroid follicular carcinoma cells through the microRNA-17/PTK6/ERK1/2 pathway. 2015 PLoS ONE pmid:25748447
Issa NP and Hentati A VZV encephalitis that developed in an immunized patient during fingolimod therapy. 2015 Neurology pmid:25416038
Lin CC et al. Sphingosine-1-phosphate mediates ICAM-1-dependent monocyte adhesion through p38 MAPK and p42/p44 MAPK-dependent Akt activation. 2015 PLoS ONE pmid:25734900
Zhang DD et al. Antinociceptive effects of FTY720 during trauma-induced neuropathic pain are mediated by spinal S1P receptors. 2015 Biol. Chem. pmid:25720064
Cozza G et al. A new role for sphingosine: Up-regulation of Fam20C, the genuine casein kinase that phosphorylates secreted proteins. 2015 Biochim. Biophys. Acta pmid:25936777
Till KJ et al. Expression of functional sphingosine-1 phosphate receptor-1 is reduced by B cell receptor signaling and increased by inhibition of PI3 kinase δ but not SYK or BTK in chronic lymphocytic leukemia cells. 2015 J. Immunol. pmid:25632006
O'Sullivan C and Dev KK Galactosylsphingosine (psychosine)-induced demyelination is attenuated by sphingosine 1-phosphate signalling. 2015 J. Cell. Sci. pmid:26359302
Slowik A et al. The sphingosine 1-phosphate receptor agonist FTY720 is neuroprotective after cuprizone-induced CNS demyelination. 2015 Br. J. Pharmacol. pmid:25220526
Oskeritzian CA et al. The sphingosine-1-phosphate/sphingosine-1-phosphate receptor 2 axis regulates early airway T-cell infiltration in murine mast cell-dependent acute allergic responses. 2015 J. Allergy Clin. Immunol. pmid:25512083
Kurano M et al. LDL receptor and ApoE are involved in the clearance of ApoM-associated sphingosine 1-phosphate. 2015 J. Biol. Chem. pmid:25505264
Konstantinou D et al. Growth factors mediated differentiation of mesenchymal stem cells to cardiac polymicrotissue using hanging drop and bioreactor. 2015 Cell Biol. Int. pmid:25492631
Opal SM and van der Poll T Endothelial barrier dysfunction in septic shock. 2015 J. Intern. Med. pmid:25418337
Frati A et al. Role of sphingosine kinase/S1P axis in ECM remodeling of cardiac cells elicited by relaxin. 2015 Mol. Endocrinol. pmid:25415609
Fustero S et al. Olefin metathesis reactions with fluorinated substrates, catalysts, and solvents. 2015 Chem. Rev. pmid:25047062
Jaramillo-Gómez J et al. Overexpression of DJ-1 protects against C2-ceramide-induced neuronal death through activation of the PI3K/AKT pathway and inhibition of autophagy. 2015 Neurosci. Lett. pmid:26222260
Klocke S et al. Slow-freezing versus vitrification for human ovarian tissue cryopreservation. 2015 Arch. Gynecol. Obstet. pmid:25115279
Czubowicz K et al. Sphingosine-1-phosphate and its effect on glucose deprivation/glucose reload stress: from gene expression to neuronal survival. 2015 Mol. Neurobiol. pmid:25056275
Siow D et al. Regulation of de novo sphingolipid biosynthesis by the ORMDL proteins and sphingosine kinase-1. 2015 Adv Biol Regul pmid:25319495
Iwabuchi K et al. Role of Ceramide from Glycosphingolipids and Its Metabolites in Immunological and Inflammatory Responses in Humans. 2015 Mediators Inflamm. pmid:26609196
Mahajan-Thakur S et al. Sphingosine-1-Phosphate and Its Receptors: A Mutual Link between Blood Coagulation and Inflammation. 2015 Mediators Inflamm. pmid:26604433
Barnawi J et al. Potential Link between the Sphingosine-1-Phosphate (S1P) System and Defective Alveolar Macrophage Phagocytic Function in Chronic Obstructive Pulmonary Disease (COPD). 2015 PLoS ONE pmid:26485657
Moruno Manchon JF et al. Cytoplasmic sphingosine-1-phosphate pathway modulates neuronal autophagy. 2015 Sci Rep pmid:26477494
Wang K et al. Alkaline Ceramidase 3 Deficiency Results in Purkinje Cell Degeneration and Cerebellar Ataxia Due to Dyshomeostasis of Sphingolipids in the Brain. 2015 PLoS Genet. pmid:26474409
Johnson CH et al. Alterations in Spinal Cord Metabolism during Treatment of Neuropathic Pain. 2015 J Neuroimmune Pharmacol pmid:26232265
Zhang SQ et al. Mutation of G234 amino acid residue in candida albicans drug-resistance-related protein Rta2p is associated with fluconazole resistance and dihydrosphingosine transport. 2015 Virulence pmid:26220356
Kihara Y et al. Lysophospholipid receptors in drug discovery. 2015 Exp. Cell Res. pmid:25499971
Le Bihan O et al. Visualization of adherent cell monolayers by cryo-electron microscopy: A snapshot of endothelial adherens junctions. 2015 J. Struct. Biol. pmid:26470813
Flávia Nardy A et al. Modulation of Intrathymic Sphingosine-1-Phosphate Levels Promotes Escape of Immature Thymocytes to the Periphery with a Potential Proinflammatory Role in Chagas Disease. 2015 Biomed Res Int pmid:26347020
Hsu CK et al. Mevastatin ameliorates sphingosine 1-phosphate-induced COX-2/PGE2-dependent cell migration via FoxO1 and CREB phosphorylation and translocation. 2015 Br. J. Pharmacol. pmid:26359950
Höglinger D et al. Intracellular sphingosine releases calcium from lysosomes. 2015 Elife pmid:26613410
Wisse P et al. Synthesis of 6-Hydroxysphingosine and α-Hydroxy Ceramide Using a Cross-Metathesis Strategy. 2015 J. Org. Chem. pmid:26061009
Gao XY et al. Inhibition of sphingosine-1-phosphate phosphatase 1 promotes cancer cells migration in gastric cancer: Clinical implications. 2015 Oncol. Rep. pmid:26239167
Adada MM et al. Intracellular sphingosine kinase 2-derived sphingosine-1-phosphate mediates epidermal growth factor-induced ezrin-radixin-moesin phosphorylation and cancer cell invasion. 2015 FASEB J. pmid:26209696
Dabkowska AP et al. Assembly of RNA nanostructures on supported lipid bilayers. 2015 Nanoscale pmid:25417592
Wang H et al. Sphingosine-1-Phosphate Induces the Migration and Angiogenesis of Epcs Through the Akt Signaling Pathway via Sphingosine-1-Phosphate Receptor 3/Platelet-Derived Growth Factor Receptor-β. 2015 Cell. Mol. Biol. Lett. pmid:26208383
Giese AK et al. A novel, highly sensitive and specific biomarker for Niemann-Pick type C1 disease. 2015 Orphanet J Rare Dis pmid:26082315
Absher JR ACP Journal Club. In multiple sclerosis, use of fingolimod reduced immune responses to influenza and tetanus booster vaccines. 2015 Ann. Intern. Med. pmid:26075785
Han SH et al. Phytosphingosine promotes megakaryocytic differentiation of myeloid leukemia cells. 2015 BMB Rep pmid:26077028
Malik FA et al. Sphingosine-1-Phosphate Is a Novel Regulator of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity. 2015 PLoS ONE pmid:26079370
Mooren OL et al. Role of N-WASP in Endothelial Monolayer Formation and Integrity. 2015 J. Biol. Chem. pmid:26070569
Zhang L et al. FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells. 2015 Toxicol. Lett. pmid:25939952
Mani R et al. ROR1-targeted delivery of OSU-2S, a nonimmunosuppressive FTY720 derivative, exerts potent cytotoxicity in mantle-cell lymphoma in vitro and in vivo. 2015 Exp. Hematol. pmid:25937048
Zonta F et al. Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A. 2015 Blood pmid:25931585
Shih HJ et al. FTY720 mitigates torsion/detorsion-induced testicular injury in rats. 2015 J. Surg. Res. pmid:25862489
Mori M Lethal arrhythmia due to fingolimod, a S1P receptor modulator: are we overestimating or underestimating? 2015 J. Neurol. Neurosurg. Psychiatry pmid:25855398
Prager B et al. Sphingosine 1-phosphate signaling at the blood-brain barrier. 2015 Trends Mol Med pmid:25939882
Rosenberg AJ et al. A practical process for the preparation of [(32)P]S1P and binding assay for S1P receptor ligands. 2015 Appl Radiat Isot pmid:25931137
Zheng XD et al. Role of Sphk1 in the malignant transformation of breast epithelial cells and breast cancer progression. 2014 Oct-Dec Indian J Cancer pmid:26842184
Rao PV Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma. 2014 Mar-Apr J Ocul Pharmacol Ther pmid:24283588
Chang N et al. Sphingosine 1-phosphate receptors negatively regulate collagen type I/III expression in human bone marrow-derived mesenchymal stem cell. 2014 J. Cell. Biochem. pmid:24038457
Fu Y et al. Impact of an immune modulator fingolimod on acute ischemic stroke. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:25489101
Tan KB et al. Liposomal codelivery of a synergistic combination of bioactive lipids in the treatment of acute myeloid leukemia. 2014 Nanomedicine (Lond) pmid:24294981
Xing Y et al. FTY720 enhances chemosensitivity of colon cancer cells to doxorubicin and etoposide via the modulation of P-glycoprotein and multidrug resistance protein 1. 2014 J Dig Dis pmid:24868599
Uhlig S et al. Differential regulation of lung endothelial permeability in vitro and in situ. 2014 Cell. Physiol. Biochem. pmid:24977477
Sedal L et al. Current management of relapsing-remitting multiple sclerosis. 2014 Intern Med J pmid:25302718
Nagamatsu T et al. Emerging roles for lysophospholipid mediators in pregnancy. 2014 Am. J. Reprod. Immunol. pmid:24689547
Gao M et al. Prolonging survival of corneal transplantation by selective sphingosine-1-phosphate receptor 1 agonist. 2014 PLoS ONE pmid:25216235
Wei N et al. Altered sphingoid base profiles in type 1 compared to type 2 diabetes. 2014 Lipids Health Dis pmid:25305670
Omidbakhsh R et al. Fingolimod affects gene expression profile associated with LPS-induced memory impairment. 2014 Exp Brain Res pmid:25098558
Xu M et al. FTY720 inhibits tubulointerstitial inflammation in albumin overload-induced nephropathy of rats via the Sphk1 pathway. 2014 Acta Pharmacol. Sin. pmid:25399649
Watanabe C et al. Antagonism and synergy of single chain sphingolipids sphingosine and sphingosine-1-phosphate toward lipid bilayer properties. Consequences for their role as cell fate regulators. 2014 Langmuir pmid:25386673
Dai Z and Green TK Synthesis of aromatic sphingosine analogues by diastereoselective amination of enantioenriched trans-γ,δ-unsaturated β-hydroxyesters. 2014 J. Org. Chem. pmid:25046474
Colombo E et al. Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide. 2014 Ann. Neurol. pmid:25043204
Leanza L et al. Correlation between potassium channel expression and sensitivity to drug-induced cell death in tumor cell lines. 2014 Curr. Pharm. Des. pmid:23701546
Yagoub D et al. Sphingosine kinase 1 isoform-specific interactions in breast cancer. 2014 Mol. Endocrinol. pmid:25216046
di Nuzzo L et al. Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis. 2014 Drug Des Devel Ther pmid:24876766
Rolin J and Maghazachi AA Implications of chemokines, chemokine receptors, and inflammatory lipids in atherosclerosis. 2014 J. Leukoc. Biol. pmid:24493826
Li MH et al. Induction of chemokine (C-C motif) ligand 2 by sphingosine-1-phosphate signaling in neuroblastoma. 2014 J. Pediatr. Surg. pmid:25092091
Marfia G et al. Autocrine/paracrine sphingosine-1-phosphate fuels proliferative and stemness qualities of glioblastoma stem cells. 2014 Glia pmid:25042636
Grammatikos G et al. Serum acid sphingomyelinase is upregulated in chronic hepatitis C infection and non alcoholic fatty liver disease. 2014 Biochim. Biophys. Acta pmid:24769340
Halmer R et al. Sphingolipids: important players in multiple sclerosis. 2014 Cell. Physiol. Biochem. pmid:24977485
Laroni A et al. Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial. 2014 BMC Neurol pmid:24690227
Arlt O et al. Sphingosine-1-phosphate modulates dendritic cell function: focus on non-migratory effects in vitro and in vivo. 2014 Cell. Physiol. Biochem. pmid:24977479
Poersch AB et al. Involvement of oxidative stress in subacute toxicity induced by fumonisin B1 in broiler chicks. 2014 Vet. Microbiol. pmid:25219295
Janes K et al. The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1. 2014 J. Biol. Chem. pmid:24876379
Zhang GQ et al. Sphingosine-1-phosphate receptors respond differently to early myocardial ischemia and ischemia-reperfusion in vivo. 2014 Sheng Li Xue Bao pmid:24777407
Jokubaitis VG et al. Fingolimod after natalizumab and the risk of short-term relapse. 2014 Neurology pmid:24610329
Ceglarek U et al. Preanalytical standardization of sphingosine-1-phosphate, sphinganine-1-phosphate and sphingosine analysis in human plasma by liquid chromatography-tandem mass spectrometry. 2014 Clin. Chim. Acta pmid:24768784
Miyazaki Y et al. Suppressed pro-inflammatory properties of circulating B cells in patients with multiple sclerosis treated with fingolimod, based on altered proportions of B-cell subpopulations. 2014 Clin. Immunol. pmid:24607506
Shin KO et al. Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells. 2014 Arch. Pharm. Res. pmid:24687256
Bird CH et al. The granzyme B-Serpinb9 axis controls the fate of lymphocytes after lysosomal stress. 2014 Cell Death Differ. pmid:24488096
Kerage D et al. Review: novel insights into the regulation of vascular tone by sphingosine 1-phosphate. 2014 Placenta pmid:24411702
Anthony DC et al. Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model. 2014 Neuropharmacology pmid:24412675
Fernández Ó et al. [Usefulness of electronic drug registers: Spanish register of patients treated with fingolimod (Gilenya ®)]. 2014 Rev Neurol pmid:24399624
Mendes-Braz M et al. The effects of glucose and lipids in steatotic and non-steatotic livers in conditions of partial hepatectomy under ischaemia-reperfusion. 2014 Liver Int. pmid:24107124
Egom EE Sphingosine-1-phosphate signalling as a therapeutic target for patients with abnormal glucose metabolism and ischaemic heart disease. 2014 J Cardiovasc Med (Hagerstown) pmid:23839592
Voon V et al. Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis--insights into possible drug mechanism. 2014 Eur. J. Clin. Pharmacol. pmid:24309839
Di Pardo A et al. FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease. 2014 Hum. Mol. Genet. pmid:24301680
Spinedi A Brefeldin A limits N-hexanoylsphingosine-induced accumulation of natural ceramide via the salvage pathway by enhancing glucosylation. 2014 Lipids pmid:24194457
Welford RW et al. Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for Niemann-Pick disease type C in a retrospective study. 2014 PLoS ONE pmid:25479233
Chawla S et al. Exogenous sphingosine 1-phosphate protects murine splenocytes against hypoxia-induced injury. 2014 Lipids pmid:24190514